Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. - Wikidata - wikimedia - TriplyDB

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.

http://www.wikidata.org/entity/Q40068184

about

Promising Therapy Candidates for Liver Fibrosis Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges The hepatic apelin system: a new therapeutic target for liver disease Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells An ex vivo model for anti-angiogenic drug testing on intact microvascular networks Systems level analysis and identification of pathways and networks associated with liver fibrosis Mechanisms of hepatic fibrogenesis Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.Current status of novel antifibrotic therapies in patients with chronic liver disease Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice.Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis Evolving therapies for liver fibrosis.CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.Hepatic fibrosis.Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs Immortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis.Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link.Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices.Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease.Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure.Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice.Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway.The chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis.Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation

P2860

Q26766727-5640B235-3B90-476C-9529-77FCBE4644EA Q26771518-4F8D9B3E-068E-406C-8CEB-6F4FF7F36571 Q26772800-323D84DC-556D-4856-9902-D001CC631B0C Q27013565-F25E6016-FF33-40DD-8543-D6422E323846 Q27023122-7653BCBC-1665-4E75-A1D3-68EE3DF4192A Q28068710-B4F0F053-C1DC-4F89-B87A-4B35BF763B29 Q28085644-8C7F4037-D5CC-413C-B671-203703EAA575 Q28272678-CAE7DEE0-DC87-4862-BE6A-E8872AA5437D Q28295197-F7EE790A-3769-4150-8E86-94FEA3D2A8CF Q28536257-96B4AAC0-203B-48D1-A802-9C87C61D6368 Q28543862-56C8431B-1AE5-4E14-9FA7-3C9E9D78D566 Q28544814-9DAC549F-5B51-4F27-B672-2C5B7A6D4ADC Q29619336-4AF23CD0-7995-4D17-9420-5A81FF57409A Q30465168-16F58B45-6FE3-4810-B936-2DC7662577E5 Q30473375-2B5F248D-596A-4BD2-8DD2-0FBA31F70B25 Q30485959-DF808C2E-A4D3-4E87-82AE-6C235ECFC879 Q30493887-69361A24-8377-449F-B73F-48B6B771F295 Q30496270-AF885C53-2E49-4F34-9E7F-99AB4DB2124C Q30539166-7D59649B-05E9-46B9-A983-8BAC2E3082AE Q30596736-A5E999ED-7E9E-405E-BCF7-39F8847A7776 Q33682848-37419819-A99D-4AB0-B0F0-2F7C9EF4FF53 Q33826258-6B4CAF64-ADDC-4E75-9D93-24F5D7C1A943 Q33904174-0ED68E40-A29A-4DD3-ADF1-D5AF74A02821 Q33920996-9CCC339C-7B0A-4B59-8020-72A22ADC6AF9 Q34209321-C95FFFE3-2CA6-42A7-9189-3FE9ACE09980 Q34354070-AC49FFB0-04D0-4BDF-9DCE-666B5DFEB564 Q34478660-6229028F-893E-410E-84F7-206927186C28 Q34786090-093B1AE2-2D09-4B1D-9E70-69801618BBB4 Q34792158-009C1EEA-997B-477A-A4C4-C57BD777D0D6 Q34902424-06FB4E33-474B-41CC-8FA3-3E92F9C8500B Q35136411-7952AA5B-56C0-4B4D-B361-8A689CFFB2B9 Q35154961-C153C343-AAC4-4A22-AEDD-4189C99A65C2 Q35458362-9D5C6B28-AB8E-40E1-A5A2-4A3331F0EED4 Q35541817-B7B08FF3-7ECB-4359-BC59-27E456E347B7 Q35626914-2EC4F7DD-358E-4CE3-8B71-3E3D1C984E90 Q35795593-EC320DB1-53D9-4B59-97D3-E9DADF5BE2C7 Q35886555-AFDBA072-5767-4EAB-89F3-FBDD308C1ED4 Q36180467-00731C3E-2F4B-4209-9EDA-FAEAB9EE6BAA Q36962774-E5BB2D11-BAD6-43C4-A7E1-8728E1C3240A Q36973713-652D3C36-A177-4A2F-A9E1-92192ADB2B79

P2860

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.

http://www.wikidata.org/entity/Q40068184

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Antiangiogenic treatment with ...... al pressure in cirrhotic rats.

@en

type

label

Antiangiogenic treatment with ...... al pressure in cirrhotic rats.

@en

prefLabel

Antiangiogenic treatment with ...... al pressure in cirrhotic rats.

@en

P1433

Q40068184-EA687C41-C314-48EE-9128-2772F58FC246

P1476

Q40068184-0B556CFE-FE30-4472-941F-2582F0246207

P2093

Q40068184-0362239E-4016-4A3E-B433-7C46DDEAC599

Q40068184-093984E3-DF46-4175-9FB3-5D6C1F7249D4

Q40068184-7262B546-9626-48D9-8D61-9FB5A6E7DFE0

Q40068184-8349CE76-67F9-41D8-9EBC-0E8CDD9251CE

Q40068184-9806EC97-2BD8-4722-87D5-4755D1A8C4F6

Q40068184-CB491E35-E05D-4E7B-9216-F7E8C5E96F41

Q40068184-EF148E1A-DED9-4687-AFA3-F6824157DA19

P2860

Q40068184-16B90237-43BF-4729-918D-FC05F492BBD2

Q40068184-2E124F16-D21B-49DC-8437-701D6B5FDD8F

Q40068184-328DEABA-1D53-4412-A745-711CA72684AC

Q40068184-351A2725-2D62-45B2-8734-2DB888D0C9B3

Q40068184-37583DDA-0380-4420-A925-34BB9CB09A58

Q40068184-45C6549B-4618-4A01-B133-DE36E2566286

Q40068184-558B6988-BBE4-4CAA-A36F-4F4447810CCD

Q40068184-678817F5-3979-4E1E-A5CE-22019118E8D3

Q40068184-680340C2-43E3-4FCC-A7C7-066E3CEE70A2

Q40068184-7D397710-84EF-4549-9729-00F46F8C2A40

P304

Q40068184-BAEB415E-EB24-454E-BF33-E52FD6024BB8

P31

Q40068184-009B5B7C-1BD0-4713-AA7C-A2FCEB8562BA

P356

Q40068184-10FBAC4D-8BC4-4443-B33E-BA0985F37A9B

P407

Q40068184-86597A39-162A-45C7-8E12-6FA31F31F3ED

P433

Q40068184-408E0D8B-E8F3-4FDA-8C7B-877E18A59F4D

P478

Q40068184-CB518F97-9B7D-40F0-BFC3-230D68DC8D0B

P50

Q40068184-16EE9297-7C02-4D75-8071-C710DD648E58

Q40068184-8B0FB6BE-BB1C-4A16-8011-9C8AF236D730

Q40068184-A32CF305-7420-49C4-8E7C-A6E1926A4B9F

P577

Q40068184-14D62727-AA33-4405-9945-F8251D8BF041

P5875

Q40068184-D69F2726-0277-4639-AFBB-18A9CFF8CCB2

P698

Q40068184-8A719F6F-9ABC-48AC-ADF5-6428E76FC6F3

P921

Q40068184-FEAB8A3F-97CB-4E80-904D-93D32004AA5D

P356

P1433

P1476

Antiangiogenic treatment with ...... tal pressure in cirrhotic rats

@en

P2093

Guillermo Fernandez-Varo

http://www.w3.org/2001/XMLSchema#string

Javier Muñoz-Luque

http://www.w3.org/2001/XMLSchema#string

Josefa Ros

http://www.w3.org/2001/XMLSchema#string

Juan Rodés

http://www.w3.org/2001/XMLSchema#string

Peter Carmeliet

http://www.w3.org/2001/XMLSchema#string

Scott L Friedman

http://www.w3.org/2001/XMLSchema#string

Sònia Tugues

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 6 induces the expression of vascular endothelial growth factor

The biology of VEGF and its receptors

Angiogenesis in life, disease and medicine

Molecular regulation of vessel maturation

Regulation of angiogenesis by hypoxia: role of the HIF system

Endothelial/pericyte interactions

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium.

Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture.

Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

P304

1919-1926

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21921

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Morales-Ruiz

Wladimiro Jiménez

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5910584

http://www.w3.org/2001/XMLSchema#string

P698

17935226

http://www.w3.org/2001/XMLSchema#string

P921